1. Home
  2. XOMA vs GILT Comparison

XOMA vs GILT Comparison

Compare XOMA & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • GILT
  • Stock Information
  • Founded
  • XOMA N/A
  • GILT 1987
  • Country
  • XOMA United States
  • GILT Israel
  • Employees
  • XOMA N/A
  • GILT N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • GILT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • XOMA Health Care
  • GILT Technology
  • Exchange
  • XOMA Nasdaq
  • GILT Nasdaq
  • Market Cap
  • XOMA 298.3M
  • GILT 298.8M
  • IPO Year
  • XOMA N/A
  • GILT 1993
  • Fundamental
  • Price
  • XOMA $28.88
  • GILT $4.70
  • Analyst Decision
  • XOMA Strong Buy
  • GILT Strong Buy
  • Analyst Count
  • XOMA 2
  • GILT 1
  • Target Price
  • XOMA $57.00
  • GILT $8.50
  • AVG Volume (30 Days)
  • XOMA 32.6K
  • GILT 225.3K
  • Earning Date
  • XOMA 08-06-2024
  • GILT 08-07-2024
  • Dividend Yield
  • XOMA N/A
  • GILT N/A
  • EPS Growth
  • XOMA N/A
  • GILT 720.00
  • EPS
  • XOMA N/A
  • GILT 0.41
  • Revenue
  • XOMA $5,811,000.00
  • GILT $283,206,000.00
  • Revenue This Year
  • XOMA $349.94
  • GILT $20.33
  • Revenue Next Year
  • XOMA $28.50
  • GILT $7.96
  • P/E Ratio
  • XOMA N/A
  • GILT $11.35
  • Revenue Growth
  • XOMA 73.10
  • GILT 14.48
  • 52 Week Low
  • XOMA $13.48
  • GILT $4.31
  • 52 Week High
  • XOMA $29.00
  • GILT $7.16
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 62.84
  • GILT 50.27
  • Support Level
  • XOMA $25.46
  • GILT $4.53
  • Resistance Level
  • XOMA $27.05
  • GILT $4.75
  • Average True Range (ATR)
  • XOMA 1.35
  • GILT 0.11
  • MACD
  • XOMA 0.34
  • GILT 0.04
  • Stochastic Oscillator
  • XOMA 97.77
  • GILT 84.37

About XOMA XOMA Corporation

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

Share on Social Networks: